Miramar Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2M | Buy |
219,421
+5,302
| +2% | +$245K | 2.4% | 24 |
|
|
2025
Q1 | $13.1M | Buy |
214,119
+35,858
| +20% | +$2.19M | 3.11% | 14 |
|
|
2024
Q4 | $10.1M | Buy |
178,261
+169,385
| +1,908% | +$9.58M | 2.4% | 22 |
|
|
2024
Q3 | $459K | Hold |
8,876
| – | – | 0.11% | 46 |
|
|
2024
Q2 | $369K | Buy |
8,876
+2,600
| +41% | +$108K | 0.09% | 50 |
|
|
2024
Q1 | $276K | Hold |
6,276
| – | – | 0.07% | 51 |
|
|
2023
Q4 | $322K | Sell |
6,276
-1,900
| -23% | -$97.5K | 0.08% | 48 |
|
|
2023
Q3 | $475K | Sell |
8,176
-1,794
| -18% | -$104K | 0.13% | 44 |
|
|
2023
Q2 | $638K | Sell |
9,970
-1,103
| -10% | -$70.5K | 0.16% | 40 |
|
|
2023
Q1 | $767K | Hold |
11,073
| – | – | 0.2% | 40 |
|
|
2022
Q4 | $797K | Sell |
11,073
-200
| -2% | -$14.4K | 0.21% | 46 |
|
|
2022
Q3 | $899K | Sell |
11,273
-518
| -4% | -$41.3K | 0.25% | 44 |
|
|
2022
Q2 | $908K | Buy |
11,791
+334
| +3% | +$25.7K | 0.26% | 42 |
|
|
2022
Q1 | $837K | Buy |
+11,457
| New | +$837K | 0.23% | 54 |
|
|
2020
Q1 | – | Sell |
-4,239
| Closed | -$273K | – | 44 |
|
|
2019
Q4 | $273K | Buy |
+4,239
| New | +$273K | 0.17% | 46 |
|